Mirati: 3Q Earnings Snapshot
SAN DIEGO (AP) _ Mirati Therapeutics Inc. (MRTX) on Monday reported a loss of $54.3 million in its third quarter.
On a per-share basis, the San Diego-based company said it had a loss of $1.38.
The results fell short of Wall Street expectations. The average estimate of seven analysts surveyed by Zacks Investment Research was for a loss of $1.27 per share.
The biopharmaceutical company posted revenue of $988,000 in the period.
Mirati shares have more than doubled since the beginning of the year. In the final minutes of trading on Monday, shares hit $97.25, more than doubling in the last 12 months.